Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04107701 · ClinicalTrials.gov registry record
Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 165
- Enrollment target
NCT04107701: Completed study, sponsored by Boston Children's Hospital.
NCT04107701 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 165 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04107701 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 165 participants
- Enrollment target
Study Summary
Investigators want to learn the role of indoor environmental exposures on respiratory symptoms, and, separately, on lung function deficits in school-aged children with bronchopulmonary dysplasia (BPD).
Primary Outcome
maximum symptom days in the prior 2 weeks assessed at completion of home sampling visits ( Units: days scale: 0-14 days with symptoms, higher is worse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2019-07-22 |
| Est. Completion | 2025-12-31 |
What the finished NCT04107701 record still lists
NCT04107701 is an observational study that tracks outcomes without assigning an intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04107701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04107701 about?
NCT04107701 is a clinical study titled "Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD". Investigators want to learn the role of indoor environmental exposures on respiratory symptoms, and, separately, on lung function deficits in school-aged children with bronchopulmonary dysplasia (BPD).
What is the current status of trial NCT04107701?
This trial is currently completed. The enrollment target is 165 participants. The study started on 2019-07-22. Estimated completion is 2025-12-31.
Who is sponsoring clinical trial NCT04107701?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI